Dr. Liye Li , MD
General Practice • Brooklyn, NY
5521 8th Ave Unit 3c
Brooklyn, NY 112203515
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on December 18, 2009; this date does not establish years in practice.
-
Published CMS data list 10,290 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Atorvastatin Calcium — 962 prescription fills, including refills.
- Losartan Potassium — 830 prescription fills, including refills.
- Vascepa (Icosapent Ethyl) — 678 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 114 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Part D prescriptions than 95% of clinicians listed under General Practice in Brooklyn, NY (2024, 26 clinicians with data). Median for this group: 171. Middle half: 46 to 737.
More Part D prescriptions than 90% of clinicians listed under General Practice in New York (2024, 186 clinicians with data). Median for this group: 462. Middle half: 50 to 2,510.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 3,893 in 2020 to 10,290 in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2020–2024.
Practice Location & Contact Primary Location
5521 8th Ave Unit 3c
Brooklyn, NY 112203515
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
General Practice: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
12,727 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$1,016,283 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $866.22 across 32 records.
By nature of payment
- Food and Beverage: $866.22 across 32 records.
Reporting-company totals (3 largest of 8)
- Gilead Sciences, Inc.: $311.27 across 12 records.
- Bayer Healthcare Pharmaceuticals Inc.: $167.62 across 6 records.
- Madrigal Pharmaceuticals: $129.63 across 1 record.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
NPI first issued
2009
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Li has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Li as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Brooklyn and New York
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
More Part D prescriptions than 95% of clinicians listed under General Practice in Brooklyn, NY (2024, 26 clinicians with data). Median for this group: 171. Middle half: 46 to 737.
More Part D prescriptions than 90% of clinicians listed under General Practice in New York (2024, 186 clinicians with data). Median for this group: 462. Middle half: 50 to 2,510.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under General Practice in Brooklyn, NY (2024, 26 clinicians with data). Median for this group: $15,428. Middle half: $505 to $76,225.
A higher Part D drug cost than 90% of clinicians listed under General Practice in New York (2024, 186 clinicians with data). Median for this group: $29,331. Middle half: $1,020 to $209,203.
82 active clinicians are listed under General Practice with a practice address in Brooklyn, NY (682 in New York).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Brooklyn
6.1% of these 82 clinicians have the CMS telehealth indicator.
18.3% of these 82 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 164% from 3,893 in 2020 to 10,290 in 2024.
- 2020: 3,893
- 2021: 5,716
- 2022: 7,177
- 2023: 8,194
- 2024: 10,290
-
30-day fills
30-day fills increased 171% from 4,703 in 2020 to 12,727 in 2024.
- 2020: 4,703
- 2021: 7,029
- 2022: 8,694
- 2023: 9,887
- 2024: 12,727
-
Part D drug cost
Part D drug cost increased 180% from $363,028 in 2020 to $1,016,283 in 2024.
- 2020: $363,028
- 2021: $696,760
- 2022: $1,013,989
- 2023: $1,053,662
- 2024: $1,016,283
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $334.40 in 2021 to $866.22 in 2025.
- 2021: $334.40
- 2022: $924.42
- 2023: $887.56
- 2024: $2,101.83
- 2025: $866.22
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 32 records totaling $866.22.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Madrigal Pharmaceuticals |
Food and Beverage
In-kind items and services
|
REZDIFFRA | General | $129.63 |
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
— | General | $125.00 |
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
— | General | $31.25 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $28.60 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $28.58 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $28.52 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $28.43 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $26.86 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $26.63 |
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
— | General | $25.00 |
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
— | General | $23.94 |
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
— | General | $23.07 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
EVENITY | General | $22.91 |
| Kowa Pharmaceuticals America, Inc. |
Food and Beverage
In-kind items and services
|
ZORYVE | General | $21.90 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
EVENITY | General | $21.82 |
| HOLOGIC INC |
Food and Beverage
In-kind items and services
|
APTIMA | General | $21.64 |
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
— | General | $21.43 |
| Merck Sharp & Dohme LLC |
Food and Beverage
In-kind items and services
|
GARDASIL 9 | General | $20.83 |
| Kowa Pharmaceuticals America, Inc. |
Food and Beverage
In-kind items and services
|
ZORYVE | General | $20.03 |
| Kowa Pharmaceuticals America, Inc. |
Food and Beverage
In-kind items and services
|
ZORYVE | General | $19.93 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
REPATHA | General | $19.67 |
| Exact Sciences Corporation |
Food and Beverage
In-kind items and services
|
Cologuard Collection Kit | General | $19.64 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
EVENITY | General | $19.64 |
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
— | General | $19.61 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
OTEZLA | General | $17.12 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 962 | 40,680 | $6,068.37 | 218 |
| Losartan Potassium | Losartan Potassium | 830 | 33,210 | $4,770.53 | 163 |
| Vascepa | Icosapent Ethyl | 678 | 21,300 | $242,104.29 | 141 |
| Amlodipine Besylate | Amlodipine Besylate | 667 | 28,470 | $3,571.31 | 141 |
| Omeprazole | Omeprazole | 435 | 14,100 | $3,337.22 | 139 |
| Metformin Hcl | Metformin Hcl | 331 | 14,220 | $1,941.16 | 72 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 318 | 15,030 | $3,792.30 | 70 |
| Tamsulosin Hcl | Tamsulosin Hcl | 310 | 12,420 | $2,616.75 | 78 |
| Alendronate Sodium | Alendronate Sodium | 276 | 9,620 | $1,259.35 | 50 |
| Diclofenac Epolamine | Diclofenac Epolamine | 238 | 6,435 | $139,467.46 | 70 |
| Fluticasone Propionate | Fluticasone Propionate | 218 | 6,570 | $2,279.02 | 91 |
| Metformin Hcl Er | Metformin Hcl | 200 | 8,550 | $804.54 | 44 |
| Metoprolol Succinate | Metoprolol Succinate | 197 | 7,990 | $1,815.31 | 43 |
| Celecoxib | Celecoxib | 171 | 6,210 | $1,489.07 | 74 |
| Meclizine Hcl | Meclizine Hcl | 170 | 2,695 | $1,279.25 | 123 |
| Zolpidem Tartrate | Zolpidem Tartrate | 163 | 4,875 | $1,055.65 | 90 |
| Halobetasol Propionate | Halobetasol Propionate | 158 | 4,715 | $10,446.01 | 100 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 156 | 5,430 | $1,781.04 | 54 |
| Diclofenac Sodium | Diclofenac Sodium | 125 | 3,543 | $44,181.37 | 74 |
| Januvia | Sitagliptin Phosphate | 121 | 5,010 | $92,128.24 | 26 |
| Tenofovir Disoproxil Fumarate | Tenofovir Disoproxil Fumarate | 118 | 4,140 | $10,777.28 | 20 |
| Simvastatin | Simvastatin | 115 | 4,740 | $690.58 | 26 |
| Montelukast Sodium | Montelukast Sodium | 105 | 3,270 | $496.11 | 48 |
| Finasteride | Finasteride | 101 | 3,690 | $464.20 | 20 |
| Ammonium Lactate | Ammonium Lactate | 93 | 2,820 | $2,598.15 | 60 |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2024-02-05NUCC Taxonomy Code: 208D00000X
A physician who specializes in the general practice of diagnosing, treating, and managing patients with a variety of illnesses and conditions.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - GENERAL PRACTICE
I20110817000664
NY
4880863752
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Nurse Practitioner - Family
DOCTORNURSEPRACTIT
Physician Assistant
RPAC
Nurse Practitioner - Family
Family Nurse Practitioner
Nurse Practitioner - Family
Family Nurse Practitioner (Certified)
Family Medicine
Doctor of Osteopathic Medicine (D.O.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 5521 8TH AVE UNIT 3C, BROOKLYN, NY 112203515 (Tel: 7184373855)
Registered at 5521 8TH AVE UNIT 3C, BROOKLYN, NY 112203515 (Tel: 7184373855)
NPI status registered as active in NPPES database
Registered at 822 54TH ST, 1FL, BROOKLYN, NY 112203254 (Tel: 7184373855)
Registered at 822 54TH ST, 1FL, BROOKLYN, NY 112203254 (Tel: 7184373855)
Recorded as LIYE LI, M.D.
General Practice (license number reported to NPPES: NY 247552)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other General Practices in Brooklyn
- Luke Edwards
- Dr. Michael Davia, MD
- Dr. Sadiasept Vargas, MD
- Dr. Momen Ismail, MD
- Chinemere Ekezie
- Dr. Catherine Sinnott, MD
Mailing Address
5521 8th Ave Unit 3c
Brooklyn, NY 112203515
Phone: 7184373855